BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 19253831)

  • 1. [Inhibitory effects of high mobility group box 1 antisense nucleotide on invasion of human pancreatic cancer cell line PCNA-1].
    Huang QX; Wang GB; Sun NF; Wang CY
    Ai Zheng; 2004 Sep; 23(9):1036-40. PubMed ID: 15363197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of endothelial cells derived from human hepatic cavernous hemangioma in vitro].
    Zhang WJ; Ye LY; Wu LQ; Xin YL; Gu F; Niu JX; Yang ZH; Lou JN
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3051-5. PubMed ID: 18261350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
    Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of vascular endothelial growth factor overexpression in ovarian tumor invasion and mechanism].
    Lu Y; Zhang A; Wang S; Li J; Wang C; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):294-7. PubMed ID: 12133405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
    Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D
    Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study the effect of antisense MMP-2 by transfection of ad-aMMP-2 on vascular endothelial cells from human proferating hemangiomas in vitro].
    Zeng FW; Cen YG; Liu XX; Xu XW; Chen JJ; Li ZY; Wu DM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):940-3. PubMed ID: 19253831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
    Sorsa T; Nwhator SO; Sakellari D; Grigoriadis A; Umeizudike KA; Brandt E; Keskin M; Tervahartiala T; Pärnänen P; Gupta S; Mohindra R; Bostanci N; Buduneli N; Räisänen IT
    Front Oral Health; 2022; 3():897115. PubMed ID: 35757444
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.